Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess

J Clin Endocrinol Metab. 1995 Nov;80(11):3145-50. doi: 10.1210/jcem.80.11.7593417.

Abstract

Four deleterious mutations are described in the gene for HSD11B2, which encodes the type 2 isoenzyme of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD2). In seven families with one or more members affected by apparent mineralocorticoid excess, this disorder is shown to be the result of a deficiency in 11 beta HSD2. Surprisingly, the patients are all homozygous for their mutation. This results from consanguinity in two families and possibly from endogamy or a founder effect in four of the other five families. The absence of compound heterozygotes remains to be investigated.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenases
  • Amino Acid Sequence
  • Child
  • Child, Preschool
  • Female
  • Genes*
  • Homozygote*
  • Humans
  • Hydroxysteroid Dehydrogenases / genetics*
  • Male
  • Metabolic Diseases / genetics*
  • Mineralocorticoids / metabolism*
  • Molecular Biology
  • Molecular Sequence Data
  • Mutation*
  • Pedigree

Substances

  • Mineralocorticoids
  • Hydroxysteroid Dehydrogenases
  • 11-beta-Hydroxysteroid Dehydrogenases